QIAGEN (QGEN)
(Delayed Data from NYSE)
$44.90 USD
-0.69 (-1.51%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $44.91 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for QIAGEN NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 341.30 | 423.21 | 512.60 | 359.19 | -41.46 |
Depreciation/Amortization & Depletion | 235.50 | 242.10 | 247.23 | 247.33 | 272.22 |
Net Change from Assets/Liabilities | -186.96 | -31.88 | -130.01 | -72.27 | -44.32 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 69.61 | 81.84 | 9.19 | -76.45 | 144.40 |
Net Cash From Operating Activities | 459.46 | 715.26 | 639.00 | 457.81 | 330.84 |
Property & Equipment | -149.71 | -129.22 | -189.90 | -132.79 | -117.95 |
Acquisition/ Disposition of Subsidiaries | -149.53 | -63.65 | 0.00 | -237.73 | -67.06 |
Investments | 291.23 | -504.00 | -40.74 | 157.09 | 96.97 |
Other Investing Activities | -79.65 | -29.89 | 28.21 | -229.86 | -134.24 |
Net Cash from Investing Activities | -87.66 | -726.76 | -202.43 | -443.28 | -222.28 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.16 | 0.12 | -92.07 | -230.96 | -72.38 |
Issuance (Repayment) of Debt | -400.00 | -108.55 | -41.35 | 201.25 | -506.40 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.64 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -33.99 | -17.37 | -16.95 | -21.05 | -60.31 |
Net Cash from Financing Activities | -433.83 | -125.80 | -150.37 | -50.13 | -639.08 |
Effect of Exchange Rate Changes | -0.56 | -12.55 | -3.68 | 4.20 | 0.83 |
Net Change In Cash & Equivalents | -62.59 | -149.85 | 282.53 | -31.41 | -529.69 |
Cash at Beginning of Period | 730.67 | 880.52 | 597.98 | 629.39 | 1,159.08 |
Cash at End of Period | 668.08 | 730.67 | 880.52 | 597.98 | 629.39 |
Diluted Net EPS | 1.48 | 1.90 | 2.28 | 1.58 | -0.19 |
Fiscal Year End for QIAGEN NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -102.79 | 80.67 | 341.30 | 243.64 | 165.82 |
Depreciation/Amortization & Depletion | 117.90 | 59.39 | 235.50 | 178.91 | 120.36 |
Net Change from Assets/Liabilities | 87.32 | -18.34 | -186.96 | -146.44 | -117.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 197.27 | 11.36 | 69.61 | 31.98 | 14.88 |
Net Cash From Operating Activities | 299.70 | 133.08 | 459.46 | 308.09 | 183.40 |
Property & Equipment | -74.77 | -36.54 | -149.71 | -98.26 | -62.32 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -149.53 | -149.53 | -149.53 |
Investments | 29.17 | 7.10 | 291.23 | 243.47 | -36.63 |
Other Investing Activities | 34.20 | 35.88 | -79.65 | -24.88 | -29.08 |
Net Cash from Investing Activities | -11.41 | 6.43 | -87.66 | -29.20 | -277.57 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.16 | 0.16 | 0.16 |
Issuance (Repayment) of Debt | -101.54 | 0.00 | -400.00 | -400.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -317.93 | -292.09 | -33.99 | -26.55 | -25.46 |
Net Cash from Financing Activities | -419.47 | -292.09 | -433.83 | -426.39 | -25.30 |
Effect of Exchange Rate Changes | -3.26 | -1.84 | -0.56 | -3.23 | -1.65 |
Net Change In Cash & Equivalents | -134.44 | -154.41 | -62.59 | -150.73 | -121.12 |
Cash at Beginning of Period | 668.08 | 668.08 | 730.67 | 730.67 | 730.67 |
Cash at End of Period | 533.64 | 513.67 | 668.08 | 579.94 | 609.55 |
Diluted Net EPS | -0.83 | 0.36 | 0.39 | 0.35 | 0.36 |